Muligt klinisk potentiale ved revertering af neuromuskulær blokade med sugammadex ved anæstesi og kirurgi

Translated title of the contribution: Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery

Emilie Øberg, Casper Claudius

Abstract

Neuromuscular blockers (NMBs) provide good conditions for endotracheal intubation and surgery. NMBs have been associated with higher morbidity and mortality, mainly due to post-operative residual neuromuscular block. This may become history with the advent of sugammadex - an antidote to the NMB rocuronium - which within 1-3 minutes neutralizes the effects of rocuronium. High-dose rocuronium is now an alternative to suxamethonium in acute or short procedures and in a situation, where ventilation/intubating cannot be performed, sugammadex can reverse the rocuronium blockade within minutes.
Translated title of the contributionPossible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery
Original languageDanish
JournalUgeskrift for Laeger
Volume175
Issue number7
Pages (from-to)428-32
Number of pages5
ISSN0041-5782
Publication statusPublished - 11 Feb 2013

Fingerprint

Dive into the research topics of 'Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery'. Together they form a unique fingerprint.

Cite this